Drug intelligence / Profile preview

Ganji Granules

Development stage
Unknown
Lead developer
Tianjiang Pharmaceutical
Administration
Oral
01

Overview

Ganji Granules (GF) is a Traditional Chinese Medicine (TCM) herbal formulation developed as an adjuvant therapy for patients with hepatocellular carcinoma (HCC) following surgical resection, local ablation, or transcatheter arterial chemoembolization (TACE). Manufactured by Jiang Yin Tian Jiang Pharmaceuticals, the formulation consists of a concentrated mixture of 14 herbs. In clinical studies, GF has demonstrated the ability to significantly extend overall survival in HCC patients, particularly those undergoing TACE, by potentially modulating the tumor microenvironment and reducing recurrence. As a botanical medicine, its therapeutic effect is attributed to the synergistic action of multiple natural compounds rather than a single molecular target.

Brand names
Ganji Granules
Other names
Ganji FormulationGanji RecipeGanji Formula肝积颗粒
02

Targets

BCL-2 (BCL-2 family)CASP9 (Caspase-9)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CASP8 (Caspase-8)CASP3 (Caspase-3)IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on Ganji Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ganji Granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call